Skip to the page

Data / Form D filings / Accolade, Inc.

Accolade, Inc.: Form D filings

Accolade, Inc., a health care company in Plymouth Meeting, PA, filed 12 Form D notices with the SEC between 2010 and 2021. The latest, on October 15, 2021, reports $11.3 million sold of a $12.5 million offering to 1 investor.

Find out what Accolade, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
660 W. GERMANTOWN PIKE SUITE 500, Plymouth Meeting, PA, 19462
Phone
(347) 574-3820
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1481646

The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 15, 2021New notice$12,500,000$11,250,000$1,250,0001Sep 30, 2021sec.gov
Jun 21, 2021New notice$390,361,282$325,275,354$65,085,92879Jun 9, 2021sec.gov
Mar 12, 2021New notice$229,999,981$129,998,958$100,001,02343Mar 3, 2021sec.gov
Oct 16, 2019New notice$20,000,038$19,999,996$421Oct 2, 2019sec.gov
Mar 30, 2018New notice$50,000,222$27,185,748$22,814,47417Mar 16, 2018sec.gov
Aug 9, 2016New notice$60,000,000$55,000,000$5,000,0004Jul 26, 2016sec.gov
Dec 7, 2015Amendment$53,600,000$38,600,001$14,999,9995Jul 6, 2015sec.gov
Jul 17, 2015New notice$35,000,000$22,500,000$12,500,0002Jul 6, 2015sec.gov
May 6, 2014New notice$2,800,000$2,800,000$01Apr 25, 2014sec.gov
Dec 23, 2013New notice$30,000,000$30,000,000$017Dec 12, 2013sec.gov
Jun 29, 2010New notice$19,722,222$16,944,444$2,777,77817Jun 14, 2010sec.gov
Jan 21, 2010New noticeIndefinite$4,000,000Indefinite15Oct 7, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Patricia J. WadorsDirector
Elizabeth J. NabelDirector
Cindy KentDirector
Peter KleinDirector
Jeff J. JordanDirector
Robert J. CavanaughExecutive Officer
Michael J. HiltonExecutive Officer
Rajeev J. SinghExecutive Officer, Director
Jeffrey BrodskyDirector
Stephen J. BarnesExecutive Officer
Thomas J. NeffDirector
Dawn J. LeporeDirector

Other health care companies in Pennsylvania that filed recently

Every Form D from the week of Oct 11, 2021 · All recent filings in Pennsylvania · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Accolade, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.